This invention provides novel stem cell-based methods for treating a number of conditions. These methods employ CD34- stem cells, and have a tremendous advantage in that they do not require myeloablation in the subject being treated. The CD34- stem cells used in the instant methods can be genetically modified or not, depending on the disorder treated.